Last update 27 Nov 2025

BGC-200134

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Pleneva, BGC 200134
Target
TGF-β1
Action
modulators
Mechanism
TGF-β1 modulators(Transforming growth factor beta 1 modulators)
Therapeutic Areas
Immune System DiseasesNervous System DiseasesOther Diseases
Active Indication-
Inactive Indication
Multiple Sclerosis, Relapsing-Remitting
Originator Organization
BTG International Ltd.BTG International Ltd.
Active Organization-
Inactive Organization
Boston Scientific Corp.Boston Scientific Corp.
License Organization-
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with BGC-200134
NCT01037907
/ TerminatedPhase 2
A Placebo-controlled Phase IIa Study of Orally Administered BGC20-0134/Pleneva TM (Structured Lipid) in Patients With RRMS
100 Clinical Results associated with BGC-200134
Login to view more data
100 Translational Medicine associated with BGC-200134
Login to view more data
100 Patents (Medical) associated with BGC-200134
Login to view more data
100 Deals associated with BGC-200134
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Multiple Sclerosis, Relapsing-RemittingPhase 2
Belgium
Boston Scientific Corp.Boston Scientific Corp.
01 Nov 2009
Multiple Sclerosis, Relapsing-RemittingPhase 2
France
Boston Scientific Corp.Boston Scientific Corp.
01 Nov 2009
Multiple Sclerosis, Relapsing-RemittingPhase 2
Germany
Boston Scientific Corp.Boston Scientific Corp.
01 Nov 2009
Multiple Sclerosis, Relapsing-RemittingPhase 2
Poland
Boston Scientific Corp.Boston Scientific Corp.
01 Nov 2009
Multiple Sclerosis, Relapsing-RemittingPhase 2
Russia
Boston Scientific Corp.Boston Scientific Corp.
01 Nov 2009
Multiple Sclerosis, Relapsing-RemittingPhase 2
Spain
Boston Scientific Corp.Boston Scientific Corp.
01 Nov 2009
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free